Why patients choose China

High value for advanced care

China is able to spread treatment cost across a very large medical system and patient base, while centralized drug procurement and national price negotiations help keep many medicines, tests, and procedures more affordable. For international patients, this often means access to high-end diagnostics and serious treatment pathways at a fraction of common US or European private-market pricing.

• 60-80% - common price reduction compared with US and European private care
• A typical MRI scan in China may be around USD 70-80, while comparable private-market pricing in the US or Europe can be several hundred to several thousand dollars.

Large clinical volume and deep experience

China has one of the world largest public hospital networks. Its Grade 3A hospitals represent the highest tier of public hospital evaluation and concentrate specialist teams, equipment, and complex-case resources. High-end private and international hospitals add multilingual service, insurance support, and a more familiar patient experience, creating complementary choices for overseas patients.

• 100M+ - annual surgeries, with some specialists handling far higher case volume
• China reports more than 10.5 billion annual medical visits, more than 1 million coronary interventions per year, and rapidly growing use of robotic surgery and oncology technologies.

Shorter diagnostic timelines

Compared with systems where specialist appointments and imaging can take weeks or months, Chinese hospitals often complete registration, imaging, lab testing, and initial direction within a much shorter window. This is driven by large-scale hospital operations, online appointment systems, electronic records, mobile payment, and dense diagnostic capacity.

• 1-3 days - common window for key checks and an initial diagnostic direction
• Ultrasound can often be arranged on the same day, while CT or MRI is commonly completed within several days depending on hospital and department availability.

International quality alignment

Many Chinese medical institutions have historically pursued JCI-style international quality and safety standards across patient safety, infection control, medication management, and surgical workflow. China has also developed CIHA, a domestic international hospital accreditation standard recognized by ISQua EEA, reflecting local hospital realities while benchmarking against global quality expectations.

• 89 - JCI-accredited institutions historically recorded in China
• CIHA recognition gives top Chinese hospitals another international framework for demonstrating service quality and patient safety to overseas patients.

• Oncology - Precision cancer care

Precision radiotherapy, immunotherapy, CAR-T pathways, and large oncology datasets support more individualized treatment planning.

• Fertility - IVF and reproductive medicine

IVF, embryo technologies, and reproductive medicine programs can offer internationally competitive outcomes at lower overall cost.

• Orthopedics - Joint, spine, and sports medicine

Joint replacement, minimally invasive spine surgery, sports medicine, and robotic assistance support faster recovery pathways.

• Hematology - Blood cancers and cell therapy

CAR-T therapy, stem-cell transplant, and specialized hematology centers give patients access to advanced treatment choices.

• Cardiology - Interventional and surgical heart care

High procedural volume in PCI, valve replacement, bypass surgery, and electrophysiology creates deep hands-on experience.

• Traditional Chinese Medicine - Recovery and chronic-care support

Acupuncture, herbal medicine, massage, and rehabilitation approaches are often used alongside modern treatment and recovery plans.